205 related articles for article (PubMed ID: 437435)
1. Complement alterations in inflammatory bowel disease.
Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune system in inflammatory bowel disease: I. Complement levels.
Hodgson HJ; Potter BJ; Jewell DP
Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune system activity in inflammatory bowel disease.
Teisberg P; Gjone E
Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
[TBL] [Abstract][Full Text] [Related]
4. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic complement in peripheral lymph of normal men.
Olszewski WL; Engeset A
Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.
Ward M; Eastwood MA
Gut; 1974 Oct; 15(10):835. PubMed ID: 4215646
[No Abstract] [Full Text] [Related]
9. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
Whaley K; Ward D; Ruddy S
Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
[TBL] [Abstract][Full Text] [Related]
10. Complement abnormalities during an epidemic of group B meningococcal infection in children.
Beatty DW; Ryder CR; Heese HD
Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
[TBL] [Abstract][Full Text] [Related]
11. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune system and ulcerative colitis activity. II. Complement level.
Hermanowicz A; Sliwiński Z; Nawarska Z; Banaś B
Arch Immunol Ther Exp (Warsz); 1984; 32(5):509-14. PubMed ID: 6152530
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
[TBL] [Abstract][Full Text] [Related]
14. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
Nakajima S; Baba AS; Tamura N
Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
[TBL] [Abstract][Full Text] [Related]
15. The effect of aging on complement activity (CH50) and complement protein levels.
Nagaki K; Hiramatsu S; Inai S; Sasaki A
J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
[TBL] [Abstract][Full Text] [Related]
16. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
17. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
18. Alterations of complement components in disease.
Luskin AT; Tobin MC
Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
[No Abstract] [Full Text] [Related]
19. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
Feinstein PA; Kaplan SR; Thayer WR
Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509
[TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of complement by Entamoeba histolytica.
Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
